摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-[(4-chlorophenyl)methoxyimino]acetic acid | 161146-55-0

中文名称
——
中文别名
——
英文名称
2-[(4-chlorophenyl)methoxyimino]acetic acid
英文别名
——
2-[(4-chlorophenyl)methoxyimino]acetic acid化学式
CAS
161146-55-0
化学式
C9H8ClNO3
mdl
——
分子量
213.62
InChiKey
KJVMYMVWBGYMBY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    120-122 °C
  • 沸点:
    362.8±44.0 °C(Predicted)
  • 密度:
    1.30±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    14
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    58.9
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    2-[(4-chlorophenyl)methoxyimino]acetic acid盐酸氢氧化钾三乙胺-硼烷 作用下, 以 1,4-二氧六环乙醇 为溶剂, 反应 6.0h, 生成 [(4-Chloro-benzyloxy)-(4-nitro-benzoyl)-amino]-acetic acid
    参考文献:
    名称:
    Synthesis and aldose reductase inhibitory activity of N-(arylsulfonyl)- and N-(aroyl)-N-(arylmethyloxy)glycines
    摘要:
    Some N-(arylsulfonyl)- C and N-(aroyl)-N-(arylmethyloxy)glycines D were synthesised and tested as aldose reductase inhibitors (ARIs). They are structurally related to the previously described ARIs of type A and B, from which they differ owing to the presence of a spacer, an OCH2 group, between the amino-acid nitrogen and the aromatic ring. The inhibitory activity was evaluated on the bovine lens aldose reductase enzyme. Compounds of types C and D show an inhibitory activity which, in the case of compounds D, is very similar to that reported for the parent compounds B. Kinetic studies carried out on the most active compound (8a), reveal that it produces an inhibition which, depending on its concentration, may be either uncompetitive or noncompetitive with respect to the substrate and the cofactor.
    DOI:
    10.1016/0223-5234(94)90138-4
  • 作为产物:
    描述:
    1-(氨基氧甲基)-4-氯苯基盐酸盐乙醛酸 作用下, 以 乙腈 为溶剂, 反应 12.0h, 以68%的产率得到2-[(4-chlorophenyl)methoxyimino]acetic acid
    参考文献:
    名称:
    Synthesis and aldose reductase inhibitory activity of N-(arylsulfonyl)- and N-(aroyl)-N-(arylmethyloxy)glycines
    摘要:
    Some N-(arylsulfonyl)- C and N-(aroyl)-N-(arylmethyloxy)glycines D were synthesised and tested as aldose reductase inhibitors (ARIs). They are structurally related to the previously described ARIs of type A and B, from which they differ owing to the presence of a spacer, an OCH2 group, between the amino-acid nitrogen and the aromatic ring. The inhibitory activity was evaluated on the bovine lens aldose reductase enzyme. Compounds of types C and D show an inhibitory activity which, in the case of compounds D, is very similar to that reported for the parent compounds B. Kinetic studies carried out on the most active compound (8a), reveal that it produces an inhibition which, depending on its concentration, may be either uncompetitive or noncompetitive with respect to the substrate and the cofactor.
    DOI:
    10.1016/0223-5234(94)90138-4
点击查看最新优质反应信息

文献信息

  • [EN] N-ACYLIMINO HETEROCYCLIC COMPOUNDS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES N-ACYLIMINO
    申请人:BASF SE
    公开号:WO2015075174A1
    公开(公告)日:2015-05-28
    The present invention relates to N-acylimino compound of formula (I): wherein X is O or S, in particular O; Y is a single bond, O, S or NR5; Het is a 5 or 6 membered carbon-bound or nitrogen-bound heterocyclic ring, W1-W2-W3-W4 represents a carbon chain group connected to N and C=N, and thus forming a saturated, unsaturated, or partially unsaturated 5 or 6 membered nitrogen containing heterocycle, wherein W1, W2, W3 and W4 each individually represent CRvVRw; R1, may be hydrogen, halogen, etc.; R3 may be hydrogen, CN, C1-C6-alkyl, etc.; R4 may be of hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkinyl, C3-C8-cycloalkyl, Q- phenyl, Q'-O-phenyl, Q'-S-phenyl, where the phenyl ring is optionally substituted with one or more, e.g. 1, 2, 3, 4 or 5 identical or different substituents R10, and the moieties Q-Het#, Q'-0-Het# and Q'-S-Het# where Het# represents a heterocyclic rad- ical and where Q and Q' are C1-C6-alkandiyl, C2-C6-alkendiyl, or C2-C6-alkyndiyl, and where Q may also be a single bond; R3 and R4 together may also may also a bivalent radical, selected from the group consisting of C2-C5-alkandiyl, C2-C5-alkendiyl, Q"-C1-C4-alkandiyl and Q"-C2-C4-alkendiyl, where Q" is O or S. The invention also relates to the use of the N-acylimino heterocyclic compounds, their stereoisomers, their tautomers and their salts, for combating invertebrate pests. Furthermore the invention relates also to methods of combating invertebrate pests, which comprises applying such compounds.
    本发明涉及式(I)的N-酰亚胺化合物:其中X为O或S,特别是O;Y为单键,O,S或NR5;Het为5或6个成员的碳键或氮键杂环,W1-W2-W3-W4代表连接到N和C=N的碳链基团,从而形成饱和的、不饱和的或部分不饱和的含氮5或6个成员的杂环,其中W1、W2、W3和W4分别表示CRvVRw;R1可能是氢、卤素等;R3可能是氢、CN、C1-C6-烷基等;R4可能是氢、C1-C6-烷基、C2-C6-烯基、C2-C6-炔基、C3-C8-环烷基、Q-苯基、Q'-O-苯基、Q'-S-苯基,其中苯环可以选择性地用一个或多个,例如1、2、3、4或5个相同或不同的取代基R10取代,以及基团Q-Het#、Q'-O-Het#和Q'-S-Het#,其中Het#表示一个杂环基团,Q和Q'为C1-C6-烷二基、C2-C6-烯二基或C2-C6-炔二基,Q也可以是单键;R3和R4联合也可以是来自C2-C5-烷二基、C2-C5-烯二基、Q"-C1-C4-烷二基和Q"-C2-C4-烯二基的二价基团,其中Q"为O或S。本发明还涉及使用N-酰亚胺杂环化合物及其立体异构体、互变异构体和盐来对抗无脊椎动物害虫。此外,本发明还涉及对抗无脊椎动物害虫的方法,包括应用这些化合物。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫